Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9CZ5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,276
Award facts
- Contract value 100% obligated
- $28,275.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,275.63 to AmerisourceBergen Drug Corp for the supply of Stelara 45 mg/0.5 mL syringes on November 24, 2025, with completion scheduled for November 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this delivery order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026.
The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. Stelara is an immunosuppressant biologic medication used to treat autoimmune conditions, and this delivery order represents a routine pharmaceutical supply requirement within the company's broader role as a pharmaceutical prime vendor. The DLA is planning next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key strategic partner in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9CZ5?
SPE2DR26F9CZ5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 24, 2025.
How much is contract SPE2DR26F9CZ5 worth?
The government has obligated $28,276 on SPE2DR26F9CZ5.
Is contract SPE2DR26F9CZ5 an order under another contract?
Yes. SPE2DR26F9CZ5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CZ5 competed?
The extent of competition for SPE2DR26F9CZ5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award